Clinical Trial Update: Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

Phase 3 study results for ThermoDox in combination with radiofrequency ablation in hepatocellular carcinoma have been completed, with results posted in 2017. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2017-03-24